The global vaccines for children market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). As people's awareness rises, the trend towards vaccination has increased. Healthcare workers prescribe a series of vaccines at birth. This vaccine is given initially to fight attacks of viral and bacterial diseases. Moreover, child-only immunization programs have come to the forefront, particularly in emerging economies, due to government agency efforts for children's health and the subsidization of vaccines. All these factors are anticipated to augment the market growth. For instance, several national government bodies in association with international bodies are trying to raise awareness regarding vaccination among people. In this respect, organizations including Bill & Melinda Gates Foundation coupled with the World Health Organization (WHO) are supporting the R&D of low-cost vaccines. 

The WHO introduced the Global Vaccine Action Plan (GVAP) back in May 2012 to ensure easy access to immunization all over the globe. The plan was authorized by 194 member states of the World Health Assembly. Adding to this, governments of various nations are providing subsidized or free-of-cost vaccination so as to reduce the risk of related diseases. Further, government bodies are funding various R&D programs to support the production of novel vaccines for new viruses. Altogether, these factors are presenting immense opportunities for the emerging demand for children vaccination. With all the benefits that vaccination offers and their awareness among people, the vaccination sector is a major contributor to the overall pharmaceutical sector. Furthermore, pediatric vaccines contribute significantly to the overall vaccination market, as most vaccinations are given at the time of birth.

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered- 

o By Disease Indication 

o By Distribution Channel

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape:  Novartis International AG, AstraZeneca plc, and GlaxoSmithKline plc, among others.

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How are players addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Vaccines for Children Market Report by Segment

By Disease Indication

• Infectious Disease
• Cancer
• CVD
• Allergy and Respiratory
• CNS
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Vaccines for Children Market by Region

North America       

• US

• Canada

Europe

• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia-Pacific    

• China

• Japan

• India

• Rest of Asia-Pacific

Rest of the World

• Latin America

• Middle East and Africa